Charles Schwab Investment Management Inc Vor Biopharma Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 17,792 shares of VOR stock, worth $24,908. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,792
Previous 17,792
-0.0%
Holding current value
$24,908
Previous $17,000
29.41%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VOR
# of Institutions
56Shares Held
41.1MCall Options Held
9.3KPut Options Held
100-
Ra Capital Management, L.P. Boston, MA22.7MShares$31.8 Million0.22% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$8.91 Million1.77% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT2.47MShares$3.45 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.74 Million0.0% of portfolio
-
Cowen And Company, LLC1.22MShares$1.71 Million0.02% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $53.3M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...